Secon Drug Screening is Laboratory Services (Healthcare) in United States that focus on comprehensive drug business. Founded in 1981. They cover business area such as provider, comprehensive drug testing and speciman collection service, criminal justice, government industry, site, detector dog team, experienced staff, all phase, substance abuse, SAMHSA, laboratory enable government, private client.
Laboratory Services (Healthcare)
1981
( 43 years old in 2024 )
Comprehensive Drug
-
Brandywine I Office Building, Suite 100
825 Kaliste Saloom Road
Lafayette, LA 70508
United States
Private
providercomprehensive drug testing and speciman collection servicecriminal justicegovernment industrysitedetector dog teamexperienced staffall phasesubstance abuseSAMHSAlaboratory enable governmentprivate client
* We use standard office opening hours in near Secon Drug Screening's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Secon Drug Screening is Laboratory Services (Healthcare) business from United States that founded in 1981 (43 years old in 2024), Secon Drug Screening business is focusing on Comprehensive Drug.
Secon Drug Screening headquarter office and corporate office address is located in Brandywine I Office Building, Suite 100 825 Kaliste Saloom Road Lafayette, LA 70508 United States.
Secon Drug Screening was founded in United States.
In 2024, Secon Drug Screening is currently focus on comprehensive drug sector.
Above is snippet of Google Trends for "comprehensive drug" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Secon Drug Screening, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
